HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

CCL3/MIP-1 alpha is not involved in the LPS-induced fever and its pyrogenic activity depends on CRF.

Abstract
The fever induced by lipopolysaccharide (LPS) depends on both prostaglandin-dependent and -independent pathways. One of the prostaglandin-independent pathways is sequentially orchestrated by pre-formed pyrogenic factor derived from LPS-stimulated macrophages (PFPF), corticotrophin releasing factor (CRF), endothelin-1 (ET-1) and interleukin-1 (IL-1). As macrophage-inflammatory-protein (MIP)-1 alpha (synonym CCL3) also induces a prostaglandin independent fever, the aim of the present study was to investigate a possible participation of CCL3/MIP-1 alpha within the prostaglandin-independent pathway of LPS-induced fever which depends on PFPF, CRF and ET-1. Therefore, rats received intracerebroventricular (i.c.v.) pre-treatment with anti-CCL3 monoclonal antibody (1 and 5 ng) at 1 h and 15 min before injection of LPS (lipopolysaccharide from E. coli; 5, 50 or 100 microg kg(-1), i.v.) or CCL3/MIP-1 alpha (500 pg, i.c.v.). Both doses of anti-CCL3 did not change the basal temperature but abolished the fever induced by CCL3/MIP-1 alpha. When given at the higher dose, anti-CCL3 did not influence the fever induced by i.v. injection of different doses of LPS, or i.c.v. administration of PFPF (200 ng), CRF (3 microg) or ET-1 (1 pmol). Bosentan, a non-selective ET(A/B) receptors antagonist (10 microg kg(-1), i.v.), reduced the fever induced by LPS but not that induced by CCL3/MIP-1 alpha. In contrast, alpha-helical CRF(9-41) (a non-selective CRF R1/R2 receptor antagonist; 25 microg injected i.c.v.) reduced CCL3/MIP-1 alpha-induced fever. In conclusion, the present results indicate that: i) CCL3/MIP-1 alpha is not an endogenous mediator of LPS-induced fever; ii) it is even not involved in the prostaglandin-independent pathway of the LPS-fever cascade and iii) its pyrogenic activity depends on synthesis/release of CRF.
AuthorsDenis Melo Soares, Maria José Figueiredo, Juliano Manvailer Martins, Renes Resende Machado, Alexandre Kanashiro, David do Carmo Malvar, Andréa Carla Pessini, Joachim Roth, Glória Emília Petto Souza
JournalBrain research (Brain Res) Vol. 1269 Pg. 54-60 (May 07 2009) ISSN: 1872-6240 [Electronic] Netherlands
PMID19285486 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Monoclonal
  • Antihypertensive Agents
  • Ccl3 protein, mouse
  • Chemokine CCL3
  • Endothelin-1
  • Lipopolysaccharides
  • Peptide Fragments
  • Recombinant Proteins
  • Sulfonamides
  • Corticotropin-Releasing Hormone
  • Bosentan
Topics
  • Animals
  • Antibodies, Monoclonal (pharmacology)
  • Antihypertensive Agents (pharmacology)
  • Bosentan
  • Chemokine CCL3 (immunology, pharmacology)
  • Corticotropin-Releasing Hormone (metabolism, pharmacology)
  • Drug Interactions
  • Endothelin-1 (metabolism)
  • Fever (chemically induced, immunology)
  • Injections, Intraventricular
  • Lipopolysaccharides (pharmacology)
  • Macrophages (immunology)
  • Male
  • Mice
  • Peptide Fragments (metabolism, pharmacology)
  • Rats
  • Rats, Wistar
  • Recombinant Proteins (immunology, pharmacology)
  • Sulfonamides (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: